← Back to Clinical Trials
Recruiting NCT07183891

NCT07183891 Performance of Large Language Models for Structured Recognition and Refractive Prediction

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07183891
Status Recruiting
Phase
Sponsor Jin Yang
Condition Cataract
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2025-08-01
Primary Completion 2030-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2025-08-01 with a primary completion date of 2030-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

We conducted a single-center, retrospective observational study to evaluate large language models (ChatGPT 4o, GPT-5, DeepSeek) for automated interpretation of de-identified IOLMaster 700 reports provided as raster images. Models produced structured biometric extraction, toric IOL recommendation, and refractive predictions (sphere, cylinder, axis). Primary outcomes included parameter-level agreement and refractive error metrics; secondary outcomes included decision-support performance for toric IOL selection and agreement on ordered T-codes. No clinical intervention was performed.

Eligibility Criteria

Inclusion Criteria: -postoperative corrected distance visual acuity (CDVA) of 0.10 logMAR or better -an absolute IOL rotational stability of less than 10∘ at the 1-month follow-up examination Exclusion Criteria: * incomplete biometric data on the examination report; * a history of previous ocular surgery or ocular trauma * the occurrence of intraoperative complications, such as an anterior capsular tear or posterior capsular rupture * the development of significant postoperative complications, including but not limited to severe intraocular infection or inadequate pupillary dilation.

Contact & Investigator

Central Contact

Xuanqiao Lin

✉ 1532483480@qq.com

📞 +8615088920668

Frequently Asked Questions

Who can join the NCT07183891 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Cataract. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07183891 currently recruiting?

Yes, NCT07183891 is actively recruiting participants. Contact the research team at 1532483480@qq.com for enrollment information.

Where is the NCT07183891 trial being conducted?

This trial is being conducted at Shanghai, China.

Who is sponsoring the NCT07183891 clinical trial?

NCT07183891 is sponsored by Jin Yang. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology